K Geissler Selected Research

K Geissler Research Topics

Disease

5	Neoplasms (Cancer) 07/2001 - 08/2000
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2003 - 01/2000
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 11/2016 - 08/2000
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2007 - 07/2000
3	Thrombocytopenia (Thrombopenia) 11/2003 - 10/2000
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2003 - 04/2001
2	Lymphoma (Lymphomas) 11/2014 - 05/2001
2	Leukemia 10/2001 - 07/2000
2	Anemia 08/2001 - 10/2000
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2014
1	Hereditary Angioedemas 11/2014
1	Thrombosis (Thrombus) 11/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2014
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2011
1	Residual Neoplasm 11/2007
1	Cytopenia 05/2003
1	Refractory Anemia with Excess of Blasts (RAEM) 05/2002
1	Refractory Anemia 05/2002
1	Blast Crisis (Blast Phase) 01/2002
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2001
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2001
1	Chloracne 08/2001
1	Leukocytosis (Pleocytosis) 08/2001
1	Acne Vulgaris 08/2001
1	Mastocytosis 07/2001
1	Liver Diseases (Liver Disease) 10/2000
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 10/2000
1	Disease Progression 10/2000
1	Hodgkin Disease (Hodgkin's Disease) 07/2000
1	Macrocytic Anemia 01/2000
1	Thrombocytosis (Thrombocythemia) 01/2000
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2000

Drug/Important Bio-Agent (IBA)

3	Tryptases (Tryptase)IBA 05/2002 - 07/2001
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2016 - 10/2000
2	Imatinib Mesylate (Gleevec)FDA Link 11/2007 - 01/2002
2	Thrombopoietin (c-mpl Ligand)IBA 11/2003 - 10/2000
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2003 - 04/2001
2	Bovine Serum AlbuminIBA 08/2000 - 07/2000
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2014
1	Inosine Triphosphate (ITP)IBA 11/2014
1	satraplatin (JM 216)IBA 01/2011
1	AnionsIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)IBA 11/2003
1	CytokinesIBA 05/2003
1	N 30IBA 05/2002
1	AntibodiesIBA 03/2002
1	Pharmaceutical PreparationsIBA 01/2002
1	Polychlorinated Dibenzodioxins (TCDD)IBA 08/2001
1	LipidsIBA 08/2001
1	AntigensIBA 07/2001
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2001
1	Interleukin-10 (Interleukin 10)IBA 05/2001
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2000
1	Immunoglobulins (Immunoglobulin)IBA 10/2000
1	fludarabineIBA 10/2000
1	Interleukin-2 (IL2)IBA 10/2000
1	Biomarkers (Surrogate Marker)IBA 10/2000
1	Neoplasm Antigens (Tumor Antigens)IBA 08/2000
1	VaccinesIBA 08/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2000
1	Interferon-alpha (Interferon Alfa)IBA 07/2000
1	1- arabinofuranosylcytosine- 5'- stearylphosphateIBA 07/2000
1	Stem Cell FactorIBA 07/2000
1	InterleukinsIBA 07/2000
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2000
1	Immunoglobulin G (IgG)IBA 01/2000
1	GlucocorticoidsIBA 01/2000
1	Prednisolone (Predate)FDA LinkGeneric 01/2000

Therapy/Procedure

5	Therapeutics 01/2002 - 01/2000
2	Drug Therapy (Chemotherapy) 11/2003 - 10/2000
1	Consolidation Chemotherapy 11/2003
1	Induction Chemotherapy 01/2000
1	Thymectomy 01/2000